Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
9,203,739
-
Share change
-
+1,386,982
-
Total reported value
-
$142,654,000
-
Price per share
-
$15.50
-
Number of holders
-
28
-
Value change
-
+$21,828,053
-
Number of buys
-
15
-
Number of sells
-
10
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2014
As of 31 Dec 2014,
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,203,739 shares.
The largest 10 holders included
ProQuest Associates IV LLC, GENERAL ELECTRIC CO, Park West Asset Management LLC, JENNISON ASSOCIATES LLC, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, THOMSON HORSTMANN & BRYANT INC, Camber Capital Management LLC, WALL STREET ASSOCIATES, and Allianz Asset Management AG.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.